(Q42630740)

English

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial

scientific article published on July 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

multicenter clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Florian Liegeois

11

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

19

object named as

Eric Delaporte

0 references

Sinata Koulla-Shiro

3

object named as

Sinata Koulla-Shiro

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Charles Kouanfack

2

object named as

Charles Kouanfack

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Eitel Mpoudi-Ngolé

18

object named as

Eitel Mpoudi-Ngolé

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Gilles Peytavin

10

object named as

Gilles Peytavin

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Alexandra Calmy

6

object named as

Alexandra Calmy

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Martine Peeters

14

object named as

Martine Peeters

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

12

object named as

Eric Nerrienet

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Christian Laurent

1

object named as

Christian Laurent

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Nathalie Nkoué

4

object named as

Nathalie Nkoué

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

5

object named as

Anke Bourgeois

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Bernadette Lactuock

7

object named as

Bernadette Lactuock

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

9

object named as

Rose Mougnutou

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

13

object named as

Michèle Tardy

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Isabelle Andrieux-Meyer

15

object named as

Isabelle Andrieux-Meyer

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Léopold Zekeng

16

object named as

Léopold Zekeng

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

author name string

Viviane Nzeusseu

8

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Michel Kazatchkine

17

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

language of work or name

0 references

publication date

1 July 2004

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

364

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

9428

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

29-34

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916586-0

7 January 2021

based on heuristic

inferred from DOI database lookup

One-sample multiple testing procedure for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916586-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916586-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid determination of nevirapine in human plasma by ion-pair reversed-phase high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916586-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of stavudine, a new antiretroviral agent, in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916586-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-performance liquid chromatographic assay for 2'-deoxy-3'-thiacytidine in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916586-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916586-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916586-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of generic zidovudine + lamivudine (Cipla, Duovir) and the GlaxoSmithKline brand (Combivir) tablets

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916586-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Adherence to HAART Regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916586-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Once-a-day highly active antiretroviral therapy in treatment-naive HIV-1-infected adults in Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916586-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916586-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916586-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916586-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916586-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916586-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916586-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916586-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916586-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(04)16586-0

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42630740&oldid=1963815909"